Introduction: While internal anal sphincter (IAS) Botox has been increasingly utilized in children with disordered defecation (DD), no literature regarding clinical efficacy or quality of life (QoL) influence exists. Therefore, we aimed to elucidate the effect of IAS Botox as an adjunct to standard treatment for DD on patient/caregiver QoL metrics in association with corresponding […]
7. Botulinum Toxin Improves Quality of Life and Clinical Outcomes in Pediatric Defecation Disorders
